(Q34388615)

1 August 2017

1 reference

title

Topical tacrolimus for the treatment of inflammatory skin diseases (English)

1 reference

1 August 2017

Assmann T

1

1 reference

1 August 2017

Homey B

series ordinal

2

1 reference

1 August 2017

Ruzicka T

series ordinal

3

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

Expert Opinion on Pharmacotherapy

1 August 2017

published in

1 reference

1 August 2017

volume

2

1 reference

1 August 2017

issue

7

1 reference

1 August 2017

page(s)

1167-1175

1 reference

The mechanism of action of cyclosporin A and FK506

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1167

FK 506 for liver, kidney, and pancreas transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1167

Liver, kidney, and thoracic organ transplantation under FK 506.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1167

A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1167

A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1167

A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1167

Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1167

NF-ATp: a transcription factor required for the co-ordinate induction of several cytokine genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1167

Human epidermal Langerhans' cells are targets for the immunosuppressive macrolide tacrolimus (FK506).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1167

Tacrolimus: a new topical immunomodulatory therapy for atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1167

Tacrolimus ointment reduces staphylococcal colonization of atopic dermatitis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1167

Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1167

Nonclinical and early clinical development of tacrolimus ointment for the treatment of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1167

FK506-induced neurotoxicity in liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1167

Tacrolimus ointment improves psoriasis in a microplaque assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1167

Erosive mucosal lichen planus: response to topical treatment with tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1167

Prevalence of childhood and adolescent atopic dermatitis in a Japanese population: comparison with the disease frequency examined 20 years ago.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1167

The prevalence of atopic dermatitis in Oregon schoolchildren

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1167

Cellular and immunologic mechanisms in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1167

Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1167

The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1167

Differential inhibition of cutaneous T-cell-mediated reactions and epidermal cell proliferation by cyclosporin A, FK-506, and rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1167

Allergic contact dermatitis from 6?-methylprednisolone aceponate and budesonide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1167

Metabolism of FK506, a potent immunosuppressive agent, by cytochrome P450 3A enzymes in rat, dog and human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1167

10.1517/14656566.2.7.1167

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference